Dynavax Technologies : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers (Form 8-K)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

Amendment to 2021 Inducement Award Plan

On June 22, 2021, the Compensation Committee of the Board of Directors of Dynavax Technologies Corporation (the 'Company') approved an amendment to increase the reserve of shares of the Company's common stock under the Dynavax Technologies Corporation 2021 Inducement Award Plan (the '2021 Inducement Award Plan') from 1,500,000 to 3,250,000 shares of common stock (subject to customary adjustments in the event of a change in capital structure of the Company) to be used exclusively for grants of inducement awards to individuals who were not previously employees or directors of the Company, other than following a bona fide period of non-employment, as a material inducement within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules to each such individual's entry into employment with the Company.

The foregoing description of the 2021 Inducement Award Plan, as amended, is not complete and is subject to, and qualified in its entirety by reference to, the complete text of the 2021 Inducement Award Plan, as amended, which will be filed with the Securities and Exchange Commission as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2021.